70
46
Growth Score 70 in past quarter
-7 pts
Heat Score 46 in past quarter
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Double Point Ventures invests in companies developing cutting-edge therapeutics, from gene therapies to precision medicines.
- Campbell Murray: Co-founder & Managing PartnerPast Role: Bioluminescence Ventures, Senior Partner
- Daniel Yadegar: Managing Partner
About the Company
Double Point Ventures invests in companies developing cutting-edge therapeutics, from gene therapies to precision medicines. While the primary focus is on novel drugs, innovative early revenue-stage diagnostic firms, medical device startups, digital health companies, and healthcare service providers that are shaping the future of healthcare are
also targeted. Backed by visionary investors, the mission is clear: to finance the scientific pioneers unraveling the medical enigmas of this era.